Correlation Between Mink Therapeutics and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Inhibrx, you can compare the effects of market volatilities on Mink Therapeutics and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Inhibrx.
Diversification Opportunities for Mink Therapeutics and Inhibrx
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mink and Inhibrx is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Inhibrx go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Inhibrx
Given the investment horizon of 90 days Mink Therapeutics is expected to generate 3.71 times more return on investment than Inhibrx. However, Mink Therapeutics is 3.71 times more volatile than Inhibrx. It trades about 0.12 of its potential returns per unit of risk. Inhibrx is currently generating about -0.01 per unit of risk. If you would invest 528.00 in Mink Therapeutics on December 25, 2024 and sell it today you would earn a total of 329.00 from holding Mink Therapeutics or generate 62.31% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Mink Therapeutics vs. Inhibrx
Performance |
Timeline |
Mink Therapeutics |
Inhibrx |
Mink Therapeutics and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mink Therapeutics and Inhibrx
The main advantage of trading using opposite Mink Therapeutics and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Inhibrx vs. Day One Biopharmaceuticals | Inhibrx vs. Replimune Group | Inhibrx vs. Mirum Pharmaceuticals | Inhibrx vs. Rocket Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |